PR Newswire
MECHANICSBURG, Pa., Aug. 4, 2016
MECHANICSBURG, Pa., Aug. 4, 2016 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its second quarter ended June 30, 2016.
For the second quarter ended June 30, 2016, net operating revenues increased 23.7% to $1,097.6 million, compared to $887.1 million for the same quarter, prior year. Income from operations was $101.1 million for the second quarter ended June 30, 2016, compared to $85.0 million for the same quarter, prior year. Net income was $40.9 million for the second quarter ended June 30, 2016, compared to $40.1 million for the same quarter, prior year. Earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, Concentra acquisition costs, Physiotherapy acquisition costs, non-operating gain (loss), and equity in earnings (losses) of unconsolidated subsidiaries ("Adjusted EBITDA") for the second quarter ended June 30, 2016 increased 23.1% to $141.5 million, compared to $114.9 million for the same quarter, prior year. During the second quarter ended June 30, 2016, we incurred Adjusted EBITDA losses associated with the closure of two specialty hospitals and Adjusted EBITDA losses for start-up hospitals approximating $9.4 million. A reconciliation of net income to Adjusted EBITDA is presented in table VIII of this release. Net income attributable to Select Medical was $33.9 million for the second quarter ended June 30, 2016, which includes a pre-tax non-operating gain of $13.0 million, compared to $36.9 million for the same quarter, prior year. Income per common share for the second quarter ended June 30, 2016 was $0.26 on a fully diluted basis, compared to income per common share of $0.28 for the same period, prior year. Excluding the non-operating gain and related tax effects, adjusted income per common share was $0.23 per diluted share for the second quarter ended June 30, 2016. A reconciliation of income per common share to adjusted income per common share for the second quarter ended June 30, 2016 is presented in table IX of this release.
For the six months ended June 30, 2016, net operating revenues increased 29.9% to $2,186.0 million, compared to $1,682.4 million for the same period, prior year. Income from operations was $187.9 million for the six months ended June 30, 2016, compared to $164.3 million for the same period, prior year. Net income was $100.8 million for the six months ended June 30, 2016, compared to $77.3 million for the same period, prior year. Adjusted EBITDA for the six months ended June 30, 2016 increased 26.3% to $270.1 million, compared to $213.8 million for the same period, prior year. During the six months ended June 30, 2016, we incurred Adjusted EBITDA losses associated with the closure of two specialty hospitals and Adjusted EBITDA losses for start-up hospitals approximating $13.7 million. A reconciliation of net income to Adjusted EBITDA is presented in table VIII of this release. Net income attributable to Select Medical was $88.8 million for the six months ended June 30, 2016, which includes a pre-tax non-operating gain of $38.1 million and a pre-tax loss on early retirement of debt of $0.8 million, compared to $72.0 million for the same period, prior year. Income per common share for the six months ended June 30, 2016 was $0.68 on a fully diluted basis, compared to income per common share of $0.55 for the same period, prior year. Excluding the non-operating gain and loss of early retirement of debt, and related tax effects, adjusted income per common share was $0.43 per diluted share for the six months ended June 30, 2016. A reconciliation of income per common share to adjusted income per common share for the six months ended June 30, 2016 is presented in table IX of this release.
Specialty Hospitals Segment
For the second quarter ended June 30, 2016, net operating revenues for the specialty hospitals segment decreased to $585.8 million, compared to $592.3 million for the same quarter, prior year. Income from operations for the specialty hospitals segment decreased to $68.9 million for the second quarter ended June 30, 2016, compared to $78.0 million for the same quarter, prior year. Adjusted EBITDA for the specialty hospitals segment decreased to $82.7 million for the second quarter ended June 30, 2016, compared to $91.4 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment was 14.1% for the second quarter ended June 30, 2016, compared to 15.4% for the same quarter, prior year. The Adjusted EBITDA results for the specialty hospitals segment include Adjusted EBITDA losses for start-up hospitals of approximately $6.6 million and $2.8 million of Adjusted EBITDA losses related to closed hospitals in the second quarter ended June 30, 2016. In the same quarter, prior year we incurred approximately $3.3 million of Adjusted EBITDA losses for start-up hospitals and $1.4 million of Adjusted EBITDA losses related to closed hospitals. Certain specialty hospitals key statistics for both the second quarters ended June 30, 2016 and 2015 are presented in table VI of this release.
For the six months ended June 30, 2016, net operating revenues for the specialty hospitals segment decreased to $1,184.8 million, compared to $1,191.1 million for the same period, prior year. Income from operations for the specialty hospitals segment decreased to $141.8 million for the second quarter ended June 30, 2016, compared to $161.3 million for the same quarter, prior year. Adjusted EBITDA for the specialty hospitals segment for the six months ended June 30, 2016 decreased to $169.5 million, compared to $187.9 million for the same period, prior year. The Adjusted EBITDA margin for the segment was 14.3% for the six months ended June 30, 2016, compared to 15.8% for the same period, prior year. The Adjusted EBITDA results for the specialty hospitals segment include Adjusted EBITDA losses for start-up hospitals of approximately $10.5 million and $3.2 million of Adjusted EBITDA losses related to closed hospitals in the six months ended June 30, 2016. In the same period, prior year we incurred approximately $8.8 million of Adjusted EBITDA losses for start-up hospitals and $0.8 million of Adjusted EBITDA losses related to closed hospitals. Certain specialty hospitals key statistics for both the six months ended June 30, 2016 and 2015 are presented in table VII of this release.
Outpatient Rehabilitation Segment
The financial results of the outpatient rehabilitation segment include the contract therapy business through March 31, 2016 and Physiotherapy beginning March 4, 2016.
For the second quarter ended June 30, 2016, net operating revenues for the outpatient rehabilitation segment increased 23.6% to $256.9 million, compared to $207.8 million for the same quarter, prior year. Income from operations for the outpatient rehabilitation segment increased 25.0% to $31.9 million for the second quarter ended June 30, 2016, compared to $25.5 million for the same quarter, prior year. Adjusted EBITDA for the segment increased 32.8% to $38.1 million for the second quarter ended June 30, 2016, compared to $28.7 million for the same quarter, prior year. The Adjusted EBITDA margin for the segment was 14.8% for the second quarter ended June 30, 2016, compared to 13.8% for the same quarter, prior year. Certain outpatient rehabilitation key statistics for both the second quarters ended June 30, 2016 and 2015 are presented in table VI of this release.
For the six months ended June 30, 2016, net operating revenues for the outpatient rehabilitation segment increased 22.5% to $495.0 million, compared to $404.2 million for the same period, prior year. Income from operations for the outpatient rehabilitation segment increased 27.5% to $56.8 million for the second quarter ended June 30, 2016, compared to $44.5 million for the same quarter, prior year. Adjusted EBITDA for the outpatient rehabilitation segment for the six months ended June 30, 2016 increased 31.8% to $67.0 million, compared to $50.9 million for the same period, prior year. The Adjusted EBITDA margin for the segment was 13.5% for the six months ended June 30, 2016, compared to 12.6% for the same period, prior year. Certain outpatient rehabilitation key statistics for both the six months ended June 30, 2016 and 2015 are presented in table VII of this release.
Concentra Segment
The financial results of Concentra, which is operated through a joint venture subsidiary, are consolidated with Select Medical's commencing on the acquisition date of June 1, 2015.
For the second quarter ended June 30, 2016, net operating revenues for the Concentra segment were $254.9 million, compared to $86.8 million for the same quarter, prior year. Income from operations for the Concentra segment was $27.9 million for the second quarter ended June 30, 2016, compared to $2.3 million for the same quarter, prior year. Adjusted EBITDA for the Concentra segment was $43.0 million for the second quarter ended June 30, 2016, compared to $11.2 million for the second quarter, prior year. The Adjusted EBITDA margin for the Concentra segment was 16.9% for the second quarter ended June 30, 2016, compared to 12.9% for the same quarter, prior year. Certain Concentra key statistics for both the second quarters ended June 30, 2016 and 2015 are presented in table VI of this release.
For the six months ended June 30, 2016, net operating revenues for the Concentra segment were $505.7 million, compared to $86.8 million for the same period, prior year. Income from operations for the Concentra segment was $46.5 million for the six months ended June 30, 2016, compared to $2.3 million for the same period, prior year. Adjusted EBITDA for the Concentra segment was $77.2 million for the six months ended June 30, 2016, compared to $11.2 million for the same period, prior year. The Adjusted EBITDA margin for the Concentra segment was 15.3% for the six months ended June 30, 2016, compared to 12.9% for the same period, prior year. Certain Concentra key statistics for the six months ended June 30, 2016 and 2015 are presented in table VII of this release.
Stock Repurchase Program
Select Medical did not repurchase shares during the six months ended June 30, 2016 under its authorized $500.0 million stock repurchase program. The program will remain in effect until December 31, 2016, unless extended or earlier terminated by the board of directors.
Business Outlook
Select Medical is updating its business outlook following reporting its second quarter 2016 financial performance. Select Medical now expects for the full year of 2016 consolidated net operating revenues to be in the range of $4.25 billion to $4.35 billion, Adjusted EBITDA for the full year of 2016 to be in the range of $500.0 million to $530.0 million, and fully diluted income per common share for the full year 2016 to be in the range of $0.87 to $1.00. Refer to table X for a reconciliation of net income to Adjusted EBITDA expectations for the full year of 2016.
Select Medical's business outlook has been updated to include the effects of the revised inpatient rehabilitation joint venture hospital openings, long term acute care hospital closures, and the effective tax rate that occurred in the most recent quarter.
Conference Call
Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 5, 2016, at 9:00am EDT. The domestic dial in number for the call is 1-877-430-7741. The international dial in number is 1-615-247-0054. The conference ID for the call is 41469974. The conference call will be webcast simultaneously and can be accessed at Select Medical Holdings Corporation's website www.selectmedicalholdings.com.
For those unable to participate in the conference call, a replay will be available until 11:59pm EDT, August 12, 2016. The replay number is 1-855-859-2056 (domestic) or 1-404-537-3406 (international). The conference ID for the replay will be 41469974. The replay can also be accessed at Select Medical Holdings Corporation's website, www.selectmedicalholdings.com.
* * * * *
Select Medical began operations in 1997 and has grown to be one of the largest operators of specialty hospitals, outpatient rehabilitation clinics and occupational health centers in the United States based on the number of facilities. As of June 30, 2016, Select Medical operated 106 long term acute care hospitals and 18 acute medical rehabilitation hospitals in 26 states and 1,600 outpatient rehabilitation clinics in 37 states and the District of Columbia. Select Medical's joint venture subsidiary Concentra operated 301 centers in 38 states. Concentra also provides contract services at employer worksites and Department of Veterans Affairs community-based outpatient clinics. At June 30, 2016, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.
Certain statements contained herein that are not descriptions of historical facts are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements due to factors including the following:
Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You should not place undue reliance on our forward-looking statements. Although we believe that the expectations reflected in forward-looking statements are reasonable, we cannot guarantee future results or performance.
Investor inquiries:
Joel T. Veit
Senior Vice President and Treasurer
717-972-1100
ir@selectmedical.com
I. Condensed Consolidated Statements of Operations | ||||||
For the Three Months Ended June 30, 2015 and 2016 (In thousands, except per share amounts, unaudited) | ||||||
| | | | | | |
| | 2015 | | 2016 | | % Change |
| | | | | | |
Net operating revenues | | $ 887,065 | | $ 1,097,631 | | 23.7% |
| | | | | | |
Costs and expenses: | | | | | | |
Cost of services | | 743,879 | | 916,985 | | 23.3% |
General and administrative | | 24,041 | | 25,870 | | 7.6% |
Bad debt expense | | 12,286 | | 17,517 | | 42.6% |
Depreciation and amortization | | 21,848 | | 36,205 | | 65.7% |
| | | | | | |
Income from operations | | 85,011 | | 101,054 | | 18.9% |
| | | | | | |
Equity in earnings of unconsolidated subsidiaries | | 3,848 | | 4,546 | | 18.1% |
Non-operating gain | | - | | 13,035 | | N/M |
Interest expense | | (25,288) | | (44,332) | | 75.3% |
| | | | | | |
Income before income taxes | | 63,571 | | 74,303 | | 16.9% |
| | | | | | |
Income tax expense | | 23,517 | | 33,450 | | 42.2% |
| | | | | | |
Net income | | 40,054 | | 40,853 | | 2.0% |
| | | | | | |
Less: Net income attributable to non- controlling interests | | 3,114 | | 6,918 | | N/M |
| | | | | | |
Net income attributable to Select Medical Holdings Corporation | | $ 36,940 | | $ 33,935 | | (8.1%) |
| | | | | | |
Weighted average shares outstanding(1): | | | | | | |
Basic | | 127,674 Werbung Mehr Nachrichten zur Select Medical Holdings Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News |